GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Series GSE114801
Query DataSets for GSE114801
Status
Public on Jan 01, 2019
Title
Trancriptomic and epigenetic analyses of mouse organoids expressing BrafV600E mutation
Organism
Mus musculus
Experiment type
Methylation profiling by high throughput sequencing
Expression profiling by array
Genome variation profiling by high throughput sequencing
Summary
This SuperSeries is composed of the SubSeries listed below.
Overall design
Refer to individual Series
Citation missing
Has this study been published? Please
login
to update or
notify GEO
.
Submission date
May 23, 2018
Last update date
Mar 21, 2019
Contact name
hari easwaran
Organization name
Johns Hopkins University
Department
Oncology
Lab
Steve Baylin
Street address
1650 Orleans Street, CRB1, Room 530
City
BALTIMORE
State/province
MD
ZIP/Postal code
21209
Country
USA
Platforms (3)
GPL10333
Agilent-026655 Whole Mouse Genome Microarray 4x44K v2 (Feature Number version)
GPL13112
Illumina HiSeq 2000 (Mus musculus)
GPL17021
Illumina HiSeq 2500 (Mus musculus)
Samples (41)
Less...
More...
GSM3150322
BRAF3_Base
GSM3150323
BRAF3_5mo
GSM3150324
BRAF3_EV
GSM3227999
OrgWT ENSW
GSM3228000
OrgWT BASE
GSM3228001
OrgBRAF1_EV ENSW
GSM3228002
OrgBRAF1_EV BASE
GSM3228003
OrgBRAF2_EV ENSW
GSM3228004
OrgBRAF2_EV BASE
GSM3228005
OrgBRAF3_EV ENSW
GSM3228006
OrgBRAF3_EV BASE
GSM3228007
OrgBRAF1_Base ENSW
GSM3228008
OrgBRAF1_Base BASE
GSM3228009
OrgBRAF2_Base ENSW
GSM3228010
OrgBRAF2_Base BASE
GSM3228011
OrgBRAF3_Base ENSW
GSM3228012
OrgBRAF3_Base BASE
GSM3228013
OrgBRAF1 ENSW
GSM3228014
OrgBRAF1 BASE
GSM3228015
OrgBRAF2 ENSW
GSM3228016
OrgBRAF2 BASE
GSM3228017
OrgBRAF3 ENSW
GSM3228018
OrgBRAF3 BASE
GSM3414866
BRAF3_Base [BiSulfite-seq]
GSM3414867
BRAF3_EV [BiSulfite-seq]
GSM3414868
BRAF1_Base [BiSulfite-seq]
GSM3414869
BRAF1_EV [BiSulfite-seq]
GSM3414870
BRAF3_EV_14m [BiSulfite-seq]
GSM3414871
BRAF3_EV_2m [BiSulfite-seq]
GSM3414872
BRAF1_EV_12m [BiSulfite-seq]
GSM3414873
BRAF1_EV_2m [BiSulfite-seq]
GSM3443211
BRAF3 organoids cultured 5 months and further grown in Base medium for 3 weeks
GSM3443212
Empty vector3 control organoids cultured 5 months and further grown in full medium for 3 weeks
GSM3443213
BRAF2 organoids cultured 5 months and further grown in Base medium for 3 weeks
GSM3443214
Empty vector2 control organoids cultured 5 months and further grown in full medium for 3 weeks
GSM3443215
BRAF1 organoids cultured 5 months and further grown in Base medium for 3 weeks
GSM3443216
Empty vector1 control organoids cultured 5 months and further grown in full medium for 3 weeks
GSM3443217
Empty vector1 control organoids cultured 2 months and further grown in full medium for 3 weeks
GSM3443218
Empty vector3 control organoids cultured 2 months and further grown in full medium for 3 weeks
GSM3443219
Empty vector1 control organoids cultured 12 months and further grown in full medium for 3 weeks
GSM3443220
Empty vector3 control organoids cultured 14 months and further grown in full medium for 3 weeks
This SuperSeries is composed of the following SubSeries:
Less...
More...
GSE114795
Trancriptomic and epigenetic analyses of mouse organoids expressing BrafV600E mutation [MBD-seq]
GSE114800
Trancriptomic and epigenetic analyses of mouse organoids expressing BrafV600E mutation [array]
GSE120759
Trancriptomic and epigenetic analyses of mouse organoids expressing BrafV600E mutation [BiSulfite-seq]
GSE121672
Transcriptomic and epigenetic analyses of mouse organoids expressing BrafV600E mutation [Exome-seq]
Relations
BioProject
PRJNA478145
Download family
Format
SOFT formatted family file(s)
SOFT
MINiML formatted family file(s)
MINiML
Series Matrix File(s)
TXT
Supplementary file
Size
Download
File type/resource
GSE114801_RAW.tar
183.3 Mb
(http)
(custom)
TAR (of TXT)
SRA Run Selector
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|